Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 1
1992 2
1993 1
1994 2
1995 3
1996 3
1997 2
1998 4
1999 1
2000 2
2001 3
2002 2
2004 3
2005 3
2006 3
2007 5
2008 11
2009 2
2010 9
2011 11
2012 17
2013 14
2014 21
2015 24
2016 14
2017 7
2018 18
2019 21
2020 10
2021 17
2022 28
2023 30
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Chen QJ, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Su YH, Hua X, Wang XY, Hong RX, Jiang KK, Song CG, Huang ZZ, Shi W, Zhong YY, Yuan ZY; South China Breast Cancer Group (SCBCG). Wang X, et al. Among authors: zhang aq. JAMA. 2021 Jan 5;325(1):50-58. doi: 10.1001/jama.2020.23370. JAMA. 2021. PMID: 33300950 Free PMC article. Clinical Trial.
Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor-Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002).
Hua X, Bi XW, Zhao JL, Shi YX, Lin Y, Wu ZY, Zhang YQ, Zhang LH, Zhang AQ, Huang H, Liu XM, Xu F, Guo Y, Xia W, Hong RX, Jiang KK, Xue C, An X, Zhong YY, Wang SS, Huang JJ, Yuan ZY. Hua X, et al. Among authors: zhang aq. Clin Cancer Res. 2022 Feb 15;28(4):637-645. doi: 10.1158/1078-0432.CCR-21-3435. Clin Cancer Res. 2022. PMID: 34810217 Free PMC article. Clinical Trial.
Combinational strategy for high-performance cancer chemotherapy.
Qin SY, Cheng YJ, Lei Q, Zhang AQ, Zhang XZ. Qin SY, et al. Among authors: zhang aq. Biomaterials. 2018 Jul;171:178-197. doi: 10.1016/j.biomaterials.2018.04.027. Epub 2018 Apr 18. Biomaterials. 2018. PMID: 29698868 Review.
Drug self-delivery systems for cancer therapy.
Qin SY, Zhang AQ, Cheng SX, Rong L, Zhang XZ. Qin SY, et al. Among authors: zhang aq. Biomaterials. 2017 Jan;112:234-247. doi: 10.1016/j.biomaterials.2016.10.016. Epub 2016 Oct 13. Biomaterials. 2017. PMID: 27768976 Review.
Saying yes to help.
Zhang AQ. Zhang AQ. Science. 2021 Jan 1;371(6524):98. doi: 10.1126/science.371.6524.98. Science. 2021. PMID: 33384379 No abstract available.
Engineering molecular imaging strategies for regenerative medicine.
Willadsen M, Chaise M, Yarovoy I, Zhang AQ, Parashurama N. Willadsen M, et al. Among authors: zhang aq. Bioeng Transl Med. 2018 Oct 21;3(3):232-255. doi: 10.1002/btm2.10114. eCollection 2018 Sep. Bioeng Transl Med. 2018. PMID: 30377663 Free PMC article. Review.
Study of the Semileptonic Decay Λ_{c}^{+}→Λe^{+}ν_{e}.
Ablikim M, Achasov MN, Adlarson P, Albrecht M, Aliberti R, Amoroso A, An MR, An Q, Bai XH, Bai Y, Bakina O, Baldini Ferroli R, Balossino I, Ban Y, Batozskaya V, Becker D, Begzsuren K, Berger N, Bertani M, Bettoni D, Bianchi F, Bloms J, Bortone A, Boyko I, Briere RA, Brueggemann A, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chang JF, Chang WL, Chelkov G, Chen C, Chen C, Chen G, Chen HS, Chen ML, Chen SJ, Chen SM, Chen T, Chen XR, Chen XT, Chen YB, Chen ZJ, Cheng WS, Choi SK, Chu X, Cibinetto G, Cossio F, Cui JJ, Dai HL, Dai JP, Dbeyssi A, de Boer RE, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong J, Dong LY, Dong MY, Dong X, Du SX, Egorov P, Fan YL, Fang J, Fang SS, Fang WX, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Feng JH, Fischer K, Fritsch M, Fritzsch C, Fu CD, Gao H, Gao YN, Gao Y, Garbolino S, Garzia I, Ge PT, Ge ZW, Geng C, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Greco M, Gu LM, Gu MH, Gu YT, Guan CY, Guo AQ, Guo LB, Guo RP, Guo YP, Guskov A, Han TT, Han WY, Hao XQ, Harris FA, He KK, He KL, Heinsius FH, Heinz CH, Heng YK, Herold C, Himmelreich M, Hou GY, Hou YR, Hou ZL, Hu HM, Hu JF, Hu T, Hu… See abstract for full author list ➔ Ablikim M, et al. Among authors: zhang aq. Phys Rev Lett. 2022 Dec 2;129(23):231803. doi: 10.1103/PhysRevLett.129.231803. Phys Rev Lett. 2022. PMID: 36563214
283 results